Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1semaglutiderybelsusischemic colitisadverse events

Case report links oral semaglutide to recurrent ischemic colitis

Symptoms returned when the 46-year-old patient was rechallenged and resolved permanently after the drug was stopped for good.

MH
By Maren Holt · Senior Reporter, GLP-1

The wire

  1. 01Spanish clinicians report a 46-year-old woman on oral semaglutide for weight loss who had three episodes of abdominal pain and hematochezia; CT, rectosigmoidoscopy and histopathology confirmed ischemic colitis.
  2. 02Authors say ischemic colitis should be considered as a rare adverse effect of GLP-1 receptor agonists when patients present with bloody diarrhea and abdominal pain.
  3. 03This is a single case report; the authors call the association probable based on temporal relationship, withdrawal response and recurrence on rechallenge, not on controlled data.

From the source

Ischemic colitis associated with oral semaglutide with recurrence upon rechallenge

Revista espanola de enfermedades digestivas · 2026 Oct 8 · Aranda Rojas S, Chen Wang Y, Tavío Hernández E et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →